Correlation Between Cullinan Oncology and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Aerovate Therapeutics, you can compare the effects of market volatilities on Cullinan Oncology and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Aerovate Therapeutics.
Diversification Opportunities for Cullinan Oncology and Aerovate Therapeutics
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cullinan and Aerovate is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Cullinan Oncology and Aerovate Therapeutics
Given the investment horizon of 90 days Cullinan Oncology LLC is expected to under-perform the Aerovate Therapeutics. In addition to that, Cullinan Oncology is 1.46 times more volatile than Aerovate Therapeutics. It trades about -0.16 of its total potential returns per unit of risk. Aerovate Therapeutics is currently generating about -0.04 per unit of volatility. If you would invest 269.00 in Aerovate Therapeutics on November 2, 2024 and sell it today you would lose (7.00) from holding Aerovate Therapeutics or give up 2.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cullinan Oncology LLC vs. Aerovate Therapeutics
Performance |
| Timeline |
| Cullinan Oncology LLC |
| Aerovate Therapeutics |
Cullinan Oncology and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cullinan Oncology and Aerovate Therapeutics
The main advantage of trading using opposite Cullinan Oncology and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.| Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
| Aerovate Therapeutics vs. Adagene | Aerovate Therapeutics vs. Acrivon Therapeutics, Common | Aerovate Therapeutics vs. Rezolute | Aerovate Therapeutics vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |